Updated: Sep 5, 2025
MC Pharma Celebrates 26 Years of Regulatory Excellence as Silver Sponsor at SAPHEX 2025
What is SAPHEX?
The South African Pharmaceutical Exhibition (SAPHEX) is Africa’s premier forum for pharmaceutical manufacturing, packaging, supply-chain and regulatory stakeholders.
- Scale & purpose — The 2025 edition hosted 100+ exhibitors and 2 000+ professionals at Johannesburg’s Sandton Convention Centre, delivering two days of expert talks, live demonstrations and networking under the banner “Uniting Healthcare.”
- Knowledge streams — Delegates moved between a GMP/GDP symposium and hands-on Strategnos workshops that covered SAHPRA inspections, pharmacovigilance, validation and logistics.
- Co-located power — SAPHEX shares the floor with The Pharmacy Show (TPS), GP Expo and The Hospital Show, giving visitors a one-stop venue where pharmacists, GPs and hospital leaders explore end-to-end healthcare innovation.
MC Pharma – 26 Years of Regulatory Depth and Market Reach
Founded in 1999, MC Pharma (Pty) Ltd. holds licences under Section 22C of the Medicines & Related Substances Act 101 of 1965 and serves as Marketing Authorisation Holder (MAH) and SAHPRA liaison for local and global clients.
Comprehensive, Modular Services
- Regulatory intelligence & eCTD publishing — 1 500+ dossiers compiled and maintained.
- Quality assurance (QA/QMS) — GMP-aligned systems, GLP/SANAS support and audit readiness.
- Sales & marketing — National key-account coverage across South Africa, Namibia, Lesotho, Botswana and Eswatini.
- Import & export logistics — Customs clearance, bonded storage and cold-chain management through various distributors and wholesalers.
Global Perspective, Local Precision
MC Pharma supports innovators from the UK, Australia, Brazil, China, India, Israel, Germany, France and the USA while contributing expertise to industry bodies such as MCA, SMASA and SAPRAA. The company’s mission upholds integrity, transparency and empowerment, safeguarding patient health by delivering compliant products to African markets.
Mnandi Pharma – Medical-Device Partner & Sister Company
Mnandi Pharma, a strategic partner to MC Pharma, focuses exclusively on medical devices and in-vitro diagnostics (Classes A–D).
Core Competencies
- 1. SAHPRA establishment licensing — Guiding manufacturers through applicant, importer and distributor approvals.
- 2. Import / export administration — Bonded storage, customs clearance and temperature-controlled consignments.
- 3. Distribution oversight — Managing national wholesaler networks for rapid, compliant rollout.
- 4. Product classification advice — Helping clients determine the correct risk class and document route.
Synergy With MC Pharma
By combining Mnandi’s device expertise with MC Pharma’s medicines portfolio, clients enjoy a single integrated partner for multi-category product launches—a strength showcased at their joint Silver Sponsor stand during SAPHEX 2025.
Why SAPHEX Matters
South Africa’s pharmaceutical market is forecast to exceed US $6 billion by 2026. SAPHEX delivers direct insight from SAHPRA, unveils first-to-market technologies and fosters partnerships essential for success in a rapidly expanding African sector.
Register Now for SAPHEX 2026
SAPHEX returns 25 – 26 March 2026 at Sandton Convention Centre, with 25% more floor space already reserved. Secure your delegate or exhibitor pass today and stay ahead in Africa’s evolving pharmaceutical landscape.
Download Event Prospectus
Download the official SAPHEX Event Prospectus to plan your participation.
SAPHEX Event Images
Contact MC Pharma for Your Regulatory Needs
With over 26 years of experience in navigating South Africa’s complex regulatory landscape, MC Pharma is your strategic partner for patient safety, regulatory excellence, and market success.
📞 +27 (012) 668 3019
✉️ pharmacist@mcpharma.co.za
🌐 Visit our website
